CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Xintela AB Company Snapshot
Xintela AB operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Xintela AB with three other miscellaneous service companies in Europe: Neurovive Pharmaceutical AB (2017 sales of 27,000.00 Swedish Kronor [US$3,032.10 ] of which 100% was Neurostat), Nanogroup SA of Poland (40,798.00 Polish New Zlotys [US$11,017.50 ] ), and Targovax ASA which is based in Norway (37,000.00 Norwegian Kroner [US$4,541.01 ] ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Xintela AB
  Stock Performance Chart for Xintela AB
 
  Stock Data: Recent Stock Performance:
  Current Price (10/12/2018): 5.60
(Figures in Swedish Kronor)
1 Week -8.8%   13 Weeks 82.4%  
4 Weeks 89.2%   52 Weeks 68.7%  
 
Xintela AB Key Data:
  Ticker: XINT Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 2,000
(Year Ending Jan 2018).
Employees: N/A
  Currency: Swedish Kronor Market Cap: 170,060,262
  Fiscal Yr Ends: December Shares Outstanding: 30,367,904
  Share Type: AKTIE Closely Held Shares: 24,863,450
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.